Healthcare · Profile from Healthcare Research Companion
Babylon Holdings Limited (Babylon Health)
The London-founded "digital-first" health company that promised to put "an affordable and accessible health service in the hands of every person on Earth" through an app, AI symptom checking and video consultations. It ran the NHS's largest GP practice (GP at Hand), a national digital service in Rwanda (Babyl) and licensing deals in Asia and Canada, raised one of Europe's largest health-tech rounds ($550m in 2019 at a valuation above $2bn), listed in New York through a SPAC at a ~$4.2bn valuation in October 2021, then bet the company on taking full financial risk for US Medicaid and Medicare patients. Revenue rose more than tenfold in two years to ~$1.1bn in 2022, but losses and cash burn grew with it, and within two years of listing Babylon had been delisted, failed to complete a rescue, shut its US business and sold its UK operations out of administration (August 2023).
At a glance
- Founded
- 2013, London (app launched 2014; reported)
- Founders
- Ali Parsa (CEO throughout), an Iranian-born former investment banker and co-founder of the hospital operator Circle Health
- Headquarters
- London; US operations based in Austin, Texas from 2021–22 (reported); the listed parent, Babylon Holdings Limited, was incorporated in Jersey
- Ownership / structure
- Private until October 2021; NYSE: BBLN from 22 October 2021 after merging with Alkuri Global Acquisition Corp.; delisted from the NYSE in mid-2023; UK subsidiaries placed in administration (Alvarez & Marsal) and US subsidiaries closed in August–September 2023 (reported)
- Leadership (at collapse)
- Ali Parsa, founder and CEO; David Humphreys, CFO (reported, verify); Kinnevik and AlbaCore Capital were the most important financial counterparties (shareholder and lender respectively)
- Segment and buyer
- Digital health / virtual primary care, later a US value-based care provider. Buyers were the NHS (capitation per registered GP patient), governments (Rwanda), insurers and corporates (licensing and white-label apps), and from 2020–21 US Medicaid and Medicare Advantage plans that paid Babylon a fixed amount per member per month and transferred medical cost risk to it
- Scale (peak)
- GP at Hand: ~100,000+ registered NHS patients, England's largest single GP list (2021–22, reported); Babyl Rwanda: ~2.6m registered users (2021, company); ~275,000+ US value-based care members at January 2022 and ~440,000 global managed-care members (company); 2022 revenue $1.11bn (+~3.5x); 2022 net loss $221.4m
- Capital raised / valuation
- ~$635m+ raised privately (Series A ~$25m 2016; Series B ~$60m 2017; Series C $550m 2019 at >$2bn; reported, verify early rounds); SPAC merger at an implied ~$4.2bn pro forma equity value with a ~$230m PIPE (2021); AlbaCore Capital debt financing (2021–23); equity effectively wiped out in 2023
- Signature moves (incl. failures)
- AI-led app and video GP service; Babyl Rwanda national partnership; NHS GP at Hand (2017); 2018 "AI matches doctors" exam claim and safety dispute; $550m Series C (2019); Royal Wolverhampton 10-year deal (2020) and exit (2022); SPAC listing (2021); full-risk US value-based care (Babylon 360, Meritage, Higi); 2023 take-private attempt, failed MindMaze merger, collapse and sale of UK business to eMed
9 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2013
Founding and Digital GP App
Founding / launch
2016
Babyl Rwanda
Launch / partnership
2017
NHS GP at Hand
Launch / partnership
2018
AI Exam Claim and Safety Dispute
AI launch / controversy
2019
Series C 550m
Funding round
2020
Royal Wolverhampton Partnership and Exit
Partnership / reversal
2021
SPAC Merger Alkuri
SPAC
2021
US Value Based Care Pivot
Pivot / acquisition
2023
Collapse and Sale to eMed
Restructuring / bankruptcy